StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Registration by Year

Novartis Registration: 2 in FY2025, down 75.0% from a year earlier.

Latest, FY2025
2
Period ended Dec 31, 2025
Change on a year earlier
-75.0%
8 in FY2024
History
3 years
Since FY2023
Sources
2
Documents cited below

Where the FY2025 figure comes from

“| Registration | 2 | 8”

Source: Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗

Reported in ESG Data Summary 2025.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Cite this data

StockData. (2026). Novartis Registration, annual FY2023–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/rd-pipeline-registration

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.